| Autor: |
Amorim CEG; Department of Biological Sciences, Columbia University, New York, NY, United States of America.; CAPES Foundation, Ministry of Education of Brazil, Brasília, DF, Brazil., Gao Z; Howard Hughes Medical Institution, Stanford University, Stanford, CA, United States of America., Baker Z; Department of Systems Biology, Columbia University, New York, NY, United States of America., Diesel JF; Universidade Federal de Santa Maria, Santa Maria, RS, Brazil., Simons YB; Department of Biological Sciences, Columbia University, New York, NY, United States of America., Haque IS; Counsyl, 180 Kimball Way, South San Francisco, CA, United States of America., Pickrell J; Department of Biological Sciences, Columbia University, New York, NY, United States of America.; New York Genome Center, New York, NY, United States of America., Przeworski M; Department of Biological Sciences, Columbia University, New York, NY, United States of America.; Department of Systems Biology, Columbia University, New York, NY, United States of America. |
| Abstrakt: |
Do the frequencies of disease mutations in human populations reflect a simple balance between mutation and purifying selection? What other factors shape the prevalence of disease mutations? To begin to answer these questions, we focused on one of the simplest cases: recessive mutations that alone cause lethal diseases or complete sterility. To this end, we generated a hand-curated set of 417 Mendelian mutations in 32 genes reported to cause a recessive, lethal Mendelian disease. We then considered analytic models of mutation-selection balance in infinite and finite populations of constant sizes and simulations of purifying selection in a more realistic demographic setting, and tested how well these models fit allele frequencies estimated from 33,370 individuals of European ancestry. In doing so, we distinguished between CpG transitions, which occur at a substantially elevated rate, and three other mutation types. Intriguingly, the observed frequency for CpG transitions is slightly higher than expectation but close, whereas the frequencies observed for the three other mutation types are an order of magnitude higher than expected, with a bigger deviation from expectation seen for less mutable types. This discrepancy is even larger when subtle fitness effects in heterozygotes or lethal compound heterozygotes are taken into account. In principle, higher than expected frequencies of disease mutations could be due to widespread errors in reporting causal variants, compensation by other mutations, or balancing selection. It is unclear why these factors would have a greater impact on disease mutations that occur at lower rates, however. We argue instead that the unexpectedly high frequency of disease mutations and the relationship to the mutation rate likely reflect an ascertainment bias: of all the mutations that cause recessive lethal diseases, those that by chance have reached higher frequencies are more likely to have been identified and thus to have been included in this study. Beyond the specific application, this study highlights the parameters likely to be important in shaping the frequencies of Mendelian disease alleles. |
